Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4. / Salomo, Louise Havkrog; Rix, Marianne; Kamper, Anne-Lise; Thomassen, Jesper Q; Sloth, Jens J; Astrup, Arne.

I: Nephrology, Dialysis, Transplantation, Bind 34, Nr. 10, 2019, s. 1691-1699.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Salomo, LH, Rix, M, Kamper, A-L, Thomassen, JQ, Sloth, JJ & Astrup, A 2019, 'Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4', Nephrology, Dialysis, Transplantation, bind 34, nr. 10, s. 1691-1699. https://doi.org/10.1093/ndt/gfy366

APA

Salomo, L. H., Rix, M., Kamper, A-L., Thomassen, J. Q., Sloth, J. J., & Astrup, A. (2019). Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4. Nephrology, Dialysis, Transplantation, 34(10), 1691-1699. https://doi.org/10.1093/ndt/gfy366

Vancouver

Salomo LH, Rix M, Kamper A-L, Thomassen JQ, Sloth JJ, Astrup A. Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4. Nephrology, Dialysis, Transplantation. 2019;34(10):1691-1699. https://doi.org/10.1093/ndt/gfy366

Author

Salomo, Louise Havkrog ; Rix, Marianne ; Kamper, Anne-Lise ; Thomassen, Jesper Q ; Sloth, Jens J ; Astrup, Arne. / Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4. I: Nephrology, Dialysis, Transplantation. 2019 ; Bind 34, Nr. 10. s. 1691-1699.

Bibtex

@article{cec11563b59749528edea28959b0b8ec,
title = "Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4",
abstract = "Background: The New Nordic Diet is a food concept favouring organically produced food items, fruits, vegetables, whole grains and fish. We investigated the short-term effects of a modified phosphorus-reduced New Nordic Renal Diet (NNRD) in chronic kidney disease (CKD) patients on important parameters of phosphorus homoeostasis.Methods: The NNRD contained a total of 850 mg phosphorus/day. A total of 18 patients, CKD Stages 3 and 4 were studied in a randomized crossover trial comparing a 1-week control period of the habitual diet with a 1-week period of the NNRD. Data were obtained at baseline and during 1 week of dietary intervention (habitual diet versus NNRD) by collecting fasting blood samples and 24-h urine collections. The primary outcome was the difference in the change in 24-h urine phosphorus excretion from baseline to Day 7 between the NNRD and habitual diet periods. Secondary outcomes were changes in the fractional excretion of phosphorus, fibroblast growth factor 23 (FGF23) and plasma phosphate.Results: As compared with the habitual diet, 24-h urine phosphorus excretion was reduced in the NNRD by 313 mg/day (P < 0.001). The mean baseline phosphorus was 875 ± 346 mg/day and was decreased by 400 ± 256 mg/day in the NNRD and 87 ± 266 mg/day in the habitual diet. The 24-h urine fractional excretion of phosphorus decreased by 11% (P < 0.001) and FGF23 decreased by 30 pg/mL (P = 0.03) with the NNRD compared with the habitual diet. Plasma phosphate did not change.Conclusion: This study demonstrates that dietary phosphorus restriction in the context of the NNRD is feasible and has positive effects on phosphorus homeostasis in CKD patients.",
keywords = "Faculty of Science, 24-h urine phosphorus excretion, Chronic kidney disease (CKD), Dietary intervention, Fibroblast growth factor 23 (FGF23), New Nordic Renal Diet (NNRD)",
author = "Salomo, {Louise Havkrog} and Marianne Rix and Anne-Lise Kamper and Thomassen, {Jesper Q} and Sloth, {Jens J} and Arne Astrup",
note = "CURIS 2019 NEXS 332",
year = "2019",
doi = "10.1093/ndt/gfy366",
language = "English",
volume = "34",
pages = "1691--1699",
journal = "Nephrology, Dialysis, Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4

AU - Salomo, Louise Havkrog

AU - Rix, Marianne

AU - Kamper, Anne-Lise

AU - Thomassen, Jesper Q

AU - Sloth, Jens J

AU - Astrup, Arne

N1 - CURIS 2019 NEXS 332

PY - 2019

Y1 - 2019

N2 - Background: The New Nordic Diet is a food concept favouring organically produced food items, fruits, vegetables, whole grains and fish. We investigated the short-term effects of a modified phosphorus-reduced New Nordic Renal Diet (NNRD) in chronic kidney disease (CKD) patients on important parameters of phosphorus homoeostasis.Methods: The NNRD contained a total of 850 mg phosphorus/day. A total of 18 patients, CKD Stages 3 and 4 were studied in a randomized crossover trial comparing a 1-week control period of the habitual diet with a 1-week period of the NNRD. Data were obtained at baseline and during 1 week of dietary intervention (habitual diet versus NNRD) by collecting fasting blood samples and 24-h urine collections. The primary outcome was the difference in the change in 24-h urine phosphorus excretion from baseline to Day 7 between the NNRD and habitual diet periods. Secondary outcomes were changes in the fractional excretion of phosphorus, fibroblast growth factor 23 (FGF23) and plasma phosphate.Results: As compared with the habitual diet, 24-h urine phosphorus excretion was reduced in the NNRD by 313 mg/day (P < 0.001). The mean baseline phosphorus was 875 ± 346 mg/day and was decreased by 400 ± 256 mg/day in the NNRD and 87 ± 266 mg/day in the habitual diet. The 24-h urine fractional excretion of phosphorus decreased by 11% (P < 0.001) and FGF23 decreased by 30 pg/mL (P = 0.03) with the NNRD compared with the habitual diet. Plasma phosphate did not change.Conclusion: This study demonstrates that dietary phosphorus restriction in the context of the NNRD is feasible and has positive effects on phosphorus homeostasis in CKD patients.

AB - Background: The New Nordic Diet is a food concept favouring organically produced food items, fruits, vegetables, whole grains and fish. We investigated the short-term effects of a modified phosphorus-reduced New Nordic Renal Diet (NNRD) in chronic kidney disease (CKD) patients on important parameters of phosphorus homoeostasis.Methods: The NNRD contained a total of 850 mg phosphorus/day. A total of 18 patients, CKD Stages 3 and 4 were studied in a randomized crossover trial comparing a 1-week control period of the habitual diet with a 1-week period of the NNRD. Data were obtained at baseline and during 1 week of dietary intervention (habitual diet versus NNRD) by collecting fasting blood samples and 24-h urine collections. The primary outcome was the difference in the change in 24-h urine phosphorus excretion from baseline to Day 7 between the NNRD and habitual diet periods. Secondary outcomes were changes in the fractional excretion of phosphorus, fibroblast growth factor 23 (FGF23) and plasma phosphate.Results: As compared with the habitual diet, 24-h urine phosphorus excretion was reduced in the NNRD by 313 mg/day (P < 0.001). The mean baseline phosphorus was 875 ± 346 mg/day and was decreased by 400 ± 256 mg/day in the NNRD and 87 ± 266 mg/day in the habitual diet. The 24-h urine fractional excretion of phosphorus decreased by 11% (P < 0.001) and FGF23 decreased by 30 pg/mL (P = 0.03) with the NNRD compared with the habitual diet. Plasma phosphate did not change.Conclusion: This study demonstrates that dietary phosphorus restriction in the context of the NNRD is feasible and has positive effects on phosphorus homeostasis in CKD patients.

KW - Faculty of Science

KW - 24-h urine phosphorus excretion

KW - Chronic kidney disease (CKD)

KW - Dietary intervention

KW - Fibroblast growth factor 23 (FGF23)

KW - New Nordic Renal Diet (NNRD)

U2 - 10.1093/ndt/gfy366

DO - 10.1093/ndt/gfy366

M3 - Journal article

C2 - 30590827

VL - 34

SP - 1691

EP - 1699

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

SN - 0931-0509

IS - 10

ER -

ID: 210787183